Drug targeting inflammation helps improve the effects of stroke

Share this article:

A new delivery method for a drug delivered to the central nervous system holds hope for treating brain inflammation that comes after a stroke, researchers have found. The effect can be realized years after a stroke, they said.

The drug, etanercept, has been successful in treating other inflammatory diseases, such as rheumatoid arthritis. The drug works by neutralizing tumor necrosis factor, a cytokine that initiates and amplifies inflammation.

When etanercept was administered to three stroke patients, all demonstrated improvement in areas such as motor function, gait, hand function, sensory deficits, spatial perception, speech and cognition within 10 minutes. The results of the study were published in Tuesday's issue of CNS Drugs.
Share this article:

More in News

White House creates new national strategy on antibiotics

White House creates new national strategy on antibiotics

The Obama administration has unveiled a national strategy to combat antibiotic-resistant bacteria. It includes an executive order to direct the federal government to "reduce the emergence and spread of antibiotic-resistant ...

Medicaid provider agreement remains legitimate during bankruptcy proceedings, judge rules

Medicaid must continue to make payments to a Florida nursing home undergoing bankruptcy proceedings, a federal judge rule recently.

Legislator pushes for more HCBS services for Medicaid beneficiaries

Medicaid beneficiaries would have an opportunity to receive more care in a home or community-based setting if a House of Representatives bill passes.